Access Biotechnology

Funding rounds backed by Access Biotechnology.

Export CSV
Funding disclosed in full
$65M
Median round
$65M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries BBiotechUnited Kingdom
12 participantsAccess BiotechnologyBritish Business BankCanaan PartnersDeep Track CapitalICGJanus Henderson InvestorsJefferson Life SciencesMarshall WaceSanofi VenturesSchroders CapitalSR OneSV Health Investors